Long-Term Data Support Efficacy, Safety of New Schizophrenia Drug

(MedPage Today) -- Recently approved xanomeline and trospium chloride (Cobenfy) demonstrated long-term efficacy and safety in patients with schizophrenia, long-term results from the phase III EMERGENT-4 trial showed.
Participants who continued...